secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2023-09-11T23:59:59+00:00
Accession:  0001193125-23-231974
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb launches $1.4B notes offering and $500M term loans to finance XIIDRA acquisition
--------------------------------------------------------------------------------

- $1.4B senior secured notes due 2028 offered via Bausch + Lomb Escrow Corp.; $500M term B loans also planned.
- Proceeds to fund acquisition of XIIDRA and other ophthalmology assets, pay fees, and repay existing debt.
- Notes offering not conditioned on acquisition close; if not closed by Sept 30, 2024, notes redeemed at principal plus interest.
- Purchase price allocation adjusted: prepaid assets reduced $22M, other liabilities cut $12M, goodwill up $10M; no impact on revenue or adjusted EBITDA.
- Acquisition expected to close around end of September 2023; term loan facility conditioned on completion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000119312523231974/0001193125-23-231974-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000119312523231974/d497585d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-231974

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer